With artificial intelligence at a pivotal moment of development, the federal government is about to transition from one that ...
Stocks are heading into December with the benchmark S&P 500 near record highs following an over 25% year-to-date gain.
Outlook Therapeutics’ eye disease drug has failed to match Roche’s Lucentis in a key trial. The biotech brushed off the ...
Indian markets rebounded on Friday after a steep decline, with Sensex gaining 805 points and Nifty50 rising 230 points.
UK car output slumped for the eighth consecutive month in October, leading the industry’s trade group to warn of further ...
Kohl’s saw sales decline in the latest quarter and now expects the full-year top line to fall 7% to 8%, creating a ...